Company / FCF Margin
ANI Pharmaceuticals, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
19.4%
FY2025
5-year range
-12.7% / 22.6%
FY2021-FY2025
Trend
+149.4%
vs FY2024
Sector context
#31 of 134
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s fcf margin of 19.4% is higher than 77% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 10 years, ranging from -12.7% in FY2022 to 73.7% in FY2019.
Based on SEC 10-K filings.
19.4% in FY2025 with a 5-year CAGR of +15.0%. Top quartile in the Health Care sector.
Declined from 22.6% to 19.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +32.1pp
- 5-Year Change
- +15.0pp
- 10-Year Change
- -
Sector benchmark
Top 23% in Health CareTop 23% of 134This company 19.4% Sector average -637.8%
▼
+103.0% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 149.4% year-over-year.
- Currently 657.2pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 19.4% | +149.4% |
| FY2024 | 7.8% | -65.6% |
| FY2023 | 22.6% | +278.5% |
| FY2022 | -12.7% | -3720.0% |
| FY2021 | 0.4% | -92.0% |
| FY2020 | 4.4% | -94.1% |
| FY2019 | 73.7% | +142.3% |
| FY2018 | 30.4% | +85.2% |
| FY2017 | 16.4% | -7.7% |
| FY2016 | 17.8% | +194.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026